Literature DB >> 9458811

Role of oxidants in influenza virus-induced gene expression.

K Knobil1, A M Choi, G W Weigand, D B Jacoby.   

Abstract

Influenza virus-induced epithelial damage may be mediated, in part, by reactive oxygen intermediates (ROIs). In this study, we investigated the role of ROIs in the influenza virus-induced gene expression of antioxidant enzymes and in the activation of nuclear factor-kappa B (NF-kappa B), an oxidant-sensitive transcriptional factor. Influenza virus infection increased production of intracellular ROIs in A549 pulmonary epithelial cells. Induction of manganese superoxide dismutase (MnSOD) mRNA correlated with increased MnSOD protein and enzyme activity. Influenza virus infection also activated NF-kappa B binding as determined by an electrophoretic mobility shift assay. Pretreatment of A549 cells with N-acetyl-L-cysteine attenuated virus-induced NF-kappa B activation and interleukin (IL)-8 mRNA induction but did not block induction of MnSOD mRNA. In contrast, pyrrolidine dithiocarbamate blocked activation of NF-kappa B and induction of MnSOD and IL-8 mRNAs. Treatment with pyrrolidine dithiocarbamate also markedly decreased virus-induced cell death. Thus oxidants are involved in influenza virus-induced activation of NF-kappa B, in the expression of IL-8 and MnSOD, and in virus-induced cell death.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9458811     DOI: 10.1152/ajplung.1998.274.1.L134

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  23 in total

Review 1.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

Review 2.  The airway epithelium: soldier in the fight against respiratory viruses.

Authors:  Marjolaine Vareille; Elisabeth Kieninger; Michael R Edwards; Nicolas Regamey
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 3.  Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development.

Authors:  Qianya Wan; Dan Song; Huangcan Li; Ming-Liang He
Journal:  Signal Transduct Target Ther       Date:  2020-07-13

4.  Therapy of experimental influenza virus infection with pyrrolidine dithiocarbamate.

Authors:  Nadine Wiesener; Christin Zimmer; Nadine Jarasch-Althof; Peter Wutzler; Andreas Henke
Journal:  Med Microbiol Immunol       Date:  2010-12-21       Impact factor: 3.402

Review 5.  Inflammatory and oxidative stress in rotavirus infection.

Authors:  Carlos A Guerrero; Orlando Acosta
Journal:  World J Virol       Date:  2016-05-12

6.  Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus.

Authors:  John C Kash; Christopher F Basler; Adolfo García-Sastre; Victoria Carter; Rosalind Billharz; David E Swayne; Ronald M Przygodzki; Jeffery K Taubenberger; Michael G Katze; Terrence M Tumpey
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 7.  Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities.

Authors:  Roberto P Garofalo; Deepthi Kolli; Antonella Casola
Journal:  Antioxid Redox Signal       Date:  2012-09-07       Impact factor: 8.401

8.  Adenovirus type 7 induces interleukin-8 in a lung slice model and requires activation of Erk.

Authors:  J L Booth; K M Coggeshall; B E Gordon; J P Metcalf
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis.

Authors:  Teluguakula Narasaraju; Edwin Yang; Ramar Perumal Samy; Huey Hian Ng; Wee Peng Poh; Audrey-Ann Liew; Meng Chee Phoon; Nico van Rooijen; Vincent T Chow
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

Review 10.  The role for N-acetylcysteine in the management of COPD.

Authors:  P N R Dekhuijzen; W J C van Beurden
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.